Aizhang Xu Postdoctoral Associate in Microbiology and Immunology

Postdoctoral Associate in Microbiology and Immunology, Microbiology and Immunology , Weill Cornell Medical College 2022 -

Publications

Sort by

Co-Author Network

selected publications

Immunogenicity and efficacy of a rationally designed vaccine against vascular endothelial growth factor in mouse solid tumor models. Cancer immunology, immunotherapy : CII. 2016 Academic Article GET IT
Times cited: 14
A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in Mice. PloS one. 2016 Academic Article GET IT
Times cited: 30

Research

Sort by

Co-investigator Network

Funding awarded

Investigation of UBR5 and its signaling as a novel target for breast cancer therapy awarded by United States Department of Defense Key Personnel 2021 - 2024
UBR5, E3 Ubiquitin Ligase, in Triple Negative Breast Cancers: Potential Role in Anti-Tumor Immunity and Cancer Metabo awarded by Qatar National Research Fund Key Personnel 2020 - 2024

Background

education and training

Ph.D., Shanghai Jiaotong University (China) 2016
M.Sc., Huazhong Agricultural University (China) 2008
B.Sc., Huazhong Agricultural University (China) 2005

Contact

full name

Aizhang Xu

primary email

aix4001@med.cornell.edu